Tit - bits

#Sell the shares of Cadila Healthcare Ltd in the

Photo: CNN Money

F&O market at around Rs.259, for short term targets of Rs.227/220. SL: Rs.264. The scrip got charged up after this pharma major, viz Cadila Healthcare recently said that its topical manufacturing facility in Gujarat has cleared US drug regulator's inspection. It was shouted up by a number of TV men. Now it is the Bear - time for the scrip.

#Sell the shares of BPCL corresponding to the spot price of Rs. 477.80, for short term targets of Rs.441/412. SL: Rs.489. )

A media report citing sources claimed that divestment in the company may be pushed beyond March 31, 2020, says the ET. 

Investors and traders should take this, as a extreme caution, as the domestic stock markets could see a "Rolling Bear Market" that may push the S&P Nifty50 down to as much as 12/15% from the current levels; if this actually happens.

If you remember,  in my earlier write up,  I have asked all of you to lighten your buy positions; though some sporadic upward mobility, in select mid and small caps cannot be ruled out.